SCHEMBL1995229

SCHEMBL1995229

O=C1NC(=O)C(c2c[nH]c3ccsc23)=C1c1nn(C2CCN3CCNCC3C2)c2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 8/20 0.38
PRKCA P17252 8/20 0.38
PRKCH P24723 8/20 0.38
PRKCE Q02156 8/20 0.38
PRKCD Q05655 8/20 0.38
PRKCB P05771 7/20 0.38
PRKCQ Q04759 7/20 0.38
PRKACA P17612 5/20 0.38
CAMK2A Q9UQM7 3/20 0.38
GSK3A P49840 3/20 0.38
PIM1 P11309 3/20 0.38
JAK3 P52333 3/20 0.38
PRKCG P05129 2/20 0.38
PRKCZ Q05513 2/20 0.38
CAMK2B Q13554 2/20 0.38
CAMK2G Q13555 2/20 0.38
PRKD3 O94806 2/20 0.38
MAP4K4 O95819 2/20 0.38
MARK3 P27448 2/20 0.38
LTK P29376 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1995932 0.88 PRKCA (0.37) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1996632 0.88 PRKCH (0.43) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1994345 0.87 PRKCA (0.40) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1997401 0.85 CAMK2D (0.53) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1990865 0.81 CAMK2D (0.45) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL2000158 0.81 PRKCH (0.46) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1997240 0.80 CAMK2D (0.41) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1995704 0.80 CAMK2D (0.41) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1994230 0.79 PRKCB (0.43) CAMK2DPRKCAPRKCHPRKCEPRKCD
SCHEMBL1992944 0.79 PRKACA (0.44) CAMK2DPRKCAPRKCHPRKCEPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO CAMK2D 2963/4885PRKCA 3438/4885PRKCH 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.